The RESIST cohort represents a central RESIST project for other RESIST projects. This is because the data of the participants can be compared with those of patients – with the aim of better understanding and treating diseases. This is done, for example, by the projects shingles and herpes virus diseases. Furthermore, the RESIST cohort cooperates with a similarly structured cohort in which younger people participate. This makes it possible to identify age-specific differences in the findings.
“We would like to understand the underlying mechanisms and identify target mechanisms that can be used for new concepts of prevention, management and therapy of the diseases,” says RESIST researcher and study leader Professor Dr. Thomas Werfel, Clinic for Dermatology, Allergology and Venerology at the Hannover Medical School (MHH). Professor Dr. Yang Li and the professors Čičin-Šain, Förster, Hühn, Illig, Krause, Osterhaus, Rimmelzwaan, Schulz, Stangel (until Sept. 2021, then Höglinger), Strowig and Werfel are helping to build the RESIST cohort. They generate the data of the patients and are going to use it.